Pretherapeutic determination of tumor resistance to chemotherapy is a main challenge, hindered by the low number of mechanisms characterized at the same time, the small size of the clinical specimens and the heterogeneity of the techniques or the lack of true quantification. The aim of the present study was to determine in real time quantitative RT-PCR, tumor cell expression of several transcripts involved in cancer cell resistance with a unique cDNA sample from a tumor biopsy. The technique had to be suitable in clinical practice for determination of several factors involved in resistance to a given drug family, for example, fluoropyrimidines resistance factors : thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine kinase (TK), dihydrofolate reductase (DHFR), folylpolyglutamate synthetase (FPGS). A frame-shifted artificial construct was designed specifically to work within the same conditions. We validated our technique by quantifying expressions of these 5 genes starting from tissue samples of colorectal carcinoma and the surrounding normal mucosa of 33 different patients. That real time quantitative RT-PCR technique using the frame-shifted artificial construct as a standard provided a real comparison and quantification of different resistance factors. Tumor resistance phenotype determination based on that approach will be investigated in a control study.
TITLE
Other drugs, such as CPT-11 or oxaliplatin, can also be used alone or combinated to 5-FU, but the development of tumor cell drug resistance remains a major obstacle to chemotherapy efficiency. Even if drug efficacy has improved mainly through drugs combination [1] [2] [3] , at least about 50% of patients undergo 2 to 3 months of treatment and sometimes severe adverse side effects before a negative response rate assessment. Characterization and then quantification of the biochemical determinants to drug response before treatment could be a useful approach to improve therapy results and avoid toxic and useless treatments.
Despite several studies, little is known about factors and parameters involved in tumor cell resistance or sensitivity to 5-FU. Many resistance factors to drugs have been previously described, mainly in vitro but also in vivo and some have been associated with poor outcome and/or response to treatment in preclinical studies [4] [5] [6] [7] [8] . Obviously, determination of a single factor is not sufficient to predict therapeutic response. However, some difficulties remain to determine the true implication of different factors in drug resistance. For a long time, most of the studies explored only one isolated resistance factor, such as thymidylate synthase (TS), the 5-FU main target [9] [10] [11] [12] [13] , and left aside other potential factors, ignoring or at least probably underestimating their respective importance and intrication. Used techniques such as radioenzymatic assay, immunohistochemistry, or semi quantitative RT-PCR, are very different and not easily reproducible and standardized. These methods have shown shortcomings in term of sensitivity, specificity or applicability in clinical practice:
radioenzymatic assay is tedious, time consuming and needs radioisotopes;
immunohistochemistry is not truly quantitative and semiquantitative RT-PCR is laborious.
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Finally this analytical heterogeneity prevents the understanding of the respective predictive value of the suspected drug resistance factors in clinical practice so far.
More and more studies confirm that simultaneous quantification of several markers would permit to improve their prediction value in outcome or response to chemotherapy [14] [15] [16] [17] [18] [19] .
The technique of real time quantitative RT-PCR appears to be an interesting approach, with a higher sensitivity than conventional methods, and a better feasibility than enzymatic techniques with small tissue samples. Actually, it allows quantifying multiple mRNAs expression with a very low amount of material. But real time RT-PCR quantification depends firstly on the accurate quantification of the used DNA standard [20] . Multiple standard molecules are classically needed when determining the expression of several genes, and this could generate some variability due to the quantification of individual DNA standard, by either spectrophotometry or fluorescence or due to the quality of the DNA preparation itself.
According to those observations, our purpose in the present study was to set up a single, simple and accurate quantitative PCR method for quantifying several resistance determinants under common amplification characteristics. This method could be a promising innovative alternative approach to achieve a real prediction of response to chemotherapy before starting a treatment.
We developed one composite standard DNA molecule for quantification of several mRNA in order to make sure we obtained accurate relative quantification of all the genes expressions. Primers sets for each studied mRNA were selected before composite standard DNA construction. Couple of primers had to work under the same PCR conditions, generate PCR products of almost the same length, and produce no amplification artefacts.
We 
MATERIALS AND METHODS

Primer design
Most of primers used in this study were designed by using primer3 freeware (http://web.umassmed.edu/bioapps/primer3_www.cgi) and obtained desalted from Invitrogen.
All primers had to work under the same conditions : annealing temperature of 55 °C, MgCl 2 final concentration of 4 mM and PCR product sizes not exceeding 500 bp (primers characteristics are depicted in Table I ).
Each pair of primers was tested by capillary PCR (Lightcycler, Roche Diagnostics) 
Composite standard DNA construction
As described in Figure 2A , addition of primer sequence was done by PCR using overlapping primers, and the first overlapping primer was added by PCR on a stuffer DNA corresponding to a 259 pb sequence of the Rat V1a receptor (nucleotide 141 to 399) [21] . All samples were checked by a pathologist before they were frozen and stored in liquid nitrogen until RNA isolation. Patients' characteristics are presented in Table II .
Total RNA extraction
Frozen tissue fragments were included in Tissue Tek (Sakura), and 10 to 20 slices 30 µm thickness were collected using a cryostat at -27°C. Total RNA was extracted immediately GAPDH, TS, TK, FPGS, DHFR and DPD mRNA were quantified starting from 2 independent RT reactions followed by PCR amplification in a one assay-run for each tissue sample.
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Statistical analysis
Results are presented as mean value +/-standard errors (SD). Statistical analysis was performed using SPSS 10.0 software. Correlations were performed using the Spearman rank test (rs). mRNA levels of the primary colorectal cancer and those of the corresponding normal mucosa were compared using the Wilcoxon signed rank test. Statistical differences between clinicopathological factors were evaluated using non parametric tests, Mann-Whitney U-test between 2 groups and Kruskall-Wallis test for 3 or more groups. A p value less than 0.05 was considered to be statistically significant.
RESULTS
Selection of PCR primer sets
Preliminary studies focused on the design of optimized primers working with good and highly comparable amplification efficiency in the standard conditions of PCR we choose efficiency of the RT reaction [22] , we tested RT-PCR protocol. We got a very good reproducibility of RT reaction as Cp value standard deviation for a single RT reaction was less than 0.2 in triplicate, and for 5 different reverse transcription reactions was less than 0.25
for each gene in a one assay-run PCR (data not shown).
Construction of the DNA composite standard
The construction of the DNA composite standard is outlined for an amplification efficiency of 100%, this could mean that SYBR green I present in the reaction could slightly inhibit the amplification.
Gene expression levels in biopsies
At first, we evaluated the integrity of total RNA extracted from tissue sample of 35 patients (couple of colorectal carcinoma and the surrounding normal mucosa) by amplification of GAPDH mRNA, after RT-PCR performed with or without MMLV-RT.
Quantification was then performed with the tissue samples of the 33 patients since 2 colorectal carcinoma samples presented significant genomic DNA contamination (data not shown).
As the purpose of our study was to truly quantify mRNA whatever the origin and/or the amount of the tissues, we had to normalize each sample in order to obtain an accurate relative quantification for every targeted gene. Quantification of the 2 housekeeping gene GAPDH and β Actin mRNA expression showed that they were significantly correlated (rs = 0,936, p < 0.001). We choosed GAPDH because it was more sensitive to genomic contamination [23, 24] , and widely used in quantification [14, 15, 25] . Then, relative mRNA levels of TS, TK, FPGS, DHFR and DPD were expressed as the ratio of targeted gene to GAPDH in order to compensate for the variation in RNA amount.
Results showed that even if expression of the 5 studied factors is widely variable, all of them were underexpressed in tumor tissue compared to normal mucosa, slightly for TK and FPGS with p < 0.05, and more significantly for TS, DHFR and DPD with p < 0.005 (Wilcoxon signed-rank test, Table III) . (Table IV) . DPD and FPGS expressions were significantly lower in women as compared to We also evaluated correlations between expression of the 5 studied genes in colorectal tumor versus normal mucosa (Table V) . Results showed profound differences since mRNA levels of the 5 different genes were generally more correlated between them in the normal mucosa than in the tumoral tissue (TK/DPD, TK/DHFR and FPGS/DPD mRNA levels only remained correlated in the colorectal carcinoma). These observations indicated differences and greater variability of tumoral tissue compared to normal mucosa. sometimes hampered because it depends highly on the accuracy of the quantification of the standard DNA used [24, 26] .
DISCUSSION
The purpose of this study was to overcome these problems by setting up a real time quantitative PCR assay using a unique composite standard DNA molecule to determine transcript expression of resistance factors under the same experimental conditions. It was specifically designed to compensate variations that could occur when quantification of several factors is needed. Moreover, the technique had to be reproducible, feasible starting biopsiessized tissue samples, easily extended in laboratories and in prospect for large scale studies.
This composite standard was set up to allow the amplification of 5 genes previously reported for their involvement in tumor resistance to 5-FU or in survival. TS, the 5-FU main target, is the most studied gene. Its overexpression is often linked to treatment failure and poor clinical outcome especially in advanced colorectal cancer [12, 15, 27, 28] . DPD is the rate-limiting enzyme of 5-FU, and has been largely studied and reported as a predictor factor.
Its underexpression in primary tumor seems to be correlated with an enhanced response to 5-FU and to survival [15, 29] . For the 3 other studied factors, increase of TK [7, 19] , DHFR [30, 31] or FPGS decrease [17, 32, 33] have also been related to a greater tumor cell resistance to 5-FU, or a worse survival. But these results are often conflicting and large-scale studies necessary for statistical validation and for proving their involvement and importance in practice have been limited.
In order to validate the method, we choose to quantify mRNA expression of the 5 transcripts, in biopsy-sized tissue samples of primary colorectal tumor and normal surrounding mucosa from 33 patients. In many previous studies, the true malignant nature of the tissue and the RNA quality could not be ascertained partly because tissues came from old tumor banks. In the present study, a pathologic exam of the tissue was again performed before RNA extraction to ensure its origin. Unfortunately, It was not possible to control the quality of extracted RNA and to quantify it by standard procedures since it was extracted from very small amount of material. To overcome the inherent variability in human tissue biopsies both in quality and quantity, the quantification was weighted with a control expressed gene, GAPDH. As the use of a housekeeping is necessary, we plan to improve the standard conception by including the primer sequences of this (or those) gene(s). Finally, the RT reaction, which could be limiting due to RNA quality or experimental conditions, was tested and we found that RT-PCR protocol was well reproducible.
Even if the population of interest was heterogeneous it permitted to validate our quantification technology. We observed an underexpression of the 5 studied genes in primary tumor when compared with the normal mucosa. Such difference has already been reported for DPD [34, 35] . There is less data for the other studied genes, and we have no explanation for this observation, except that mucosa is a fast renewing tissue.
Correlations were also observed between several clinicopathological parameters and the expression of the 5 genes.
Decreased FPGS and DPD mRNA expressions were found in women colorectal carcinoma as compared to men tumors whereas this difference was not observed in normal mucosa. Tumors with low DPD expression are considered to be more sensitive to 5-FU.
Female gender is often considered as a positive prognostic factor in colorectal cancer, and more recently as a positive factor for 5-FU adjuvant chemotherapy [36] . Such DPD underexpression in women primary tumor has been previously reported [37, 38] and it was proposed that low DPD expression observed in women tumor is problably associated with a better prognostic value for 5-FU chemotherapy.
Results also showed a decreased TS expression in well differentiated colorectal primary tumors. This observation is in agreement with the meaning that low TS expression is of better prognosis for survival, since well differentiated tumor are more aggressive.
Curiously, we also noticed that DHFR mRNA level was underexpressed in colorectal cancer in the case of "B" group which include metastatic diseases and local relapse. Folates present dual modulatory effects on carcinogenesis, but several points in the literature suggest that this observation might be of interest. Indeed, numerous studies suggested that low folate intake increased carcinogenesis [39, 40] . Moreover DHF and methyl-THF had an antiproliferative effect in human colon cancer cell line in vitro [41, 42] . At last, Levy and coll.
showed that low DHFR mRNA expression correlated significantly with poor outcome in acute lymphocytic leukaemia [43] . It could mean that decrease of DHFR expression might reproduce cellular conditions close to low folate intake, conditions related to carcinogenesis and maybe to the severity of the tumoral disease. 
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